End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.072 AUD | 0.00% | -4.00% | +22.03% |
20/05 | Percheron Therapeutics Secures US Patent for Muscular Dystrophy Medicinal Candidate | MT |
06/05 | WHO Selects International Nonproprietary Name for Percheron Therapeutics' Drug Candidate ATL1102 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.03% | 43.21M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- PER Stock
- News Percheron Therapeutics Limited
- Antisense Therapeutics Receives R&D Rebate of Nearly $580,000